How can epidemiological studies be designed to include immunocompromised populations?
Epidemiological studies need to be meticulously designed to include immunocompromised populations. This includes stratifying data to differentiate between immunocompromised and immunocompetent individuals, understanding the specific risk factors and outcomes in these subgroups, and tailoring interventional studies to assess the efficacy and safety of treatments in these populations.
